▶ 調査レポート

生物学的治療薬の世界市場(~2026年)

• 英文タイトル:Global Biologic Therapeutics Drugs Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。生物学的治療薬の世界市場(~2026年) / Global Biologic Therapeutics Drugs Market Insights and Forecast to 2026 / MRC2-11QY03233資料のイメージです。• レポートコード:MRC2-11QY03233
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は生物学的治療薬のグローバル市場について調査・分析したレポートです。種類別(ヒト、鳥類細胞培養、酵母、細菌、昆虫細胞培養、トランスジェニック)市場規模、用途別(関節リウマチ、貧血、がん、糖尿病、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別生物学的治療薬の競争状況、市場シェア
・世界の生物学的治療薬市場:種類別市場規模 2015年-2020年(ヒト、鳥類細胞培養、酵母、細菌、昆虫細胞培養、トランスジェニック)
・世界の生物学的治療薬市場:種類別市場規模予測 2021年-2026年(ヒト、鳥類細胞培養、酵母、細菌、昆虫細胞培養、トランスジェニック)
・世界の生物学的治療薬市場:用途別市場規模 2015年-2020年(関節リウマチ、貧血、がん、糖尿病、その他)
・世界の生物学的治療薬市場:用途別市場規模予測 2021年-2026年(関節リウマチ、貧血、がん、糖尿病、その他)
・北米の生物学的治療薬市場分析:米国、カナダ
・ヨーロッパの生物学的治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの生物学的治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の生物学的治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの生物学的治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、AstraZeneca、Novartis、Merck、Smith Medical、GlaxoSmithKline、Concord Biotech、Aurobindo Pharma、H. Lundbeck、Retractable Technologies
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

Market Analysis and Insights: Global Biologic Therapeutics Drugs Market
The global Biologic Therapeutics Drugs market size is projected to reach US$ 343370 million by 2026, from US$ 322420 million in 2020, at a CAGR of 6.0%% during 2021-2026.

Global Biologic Therapeutics Drugs Scope and Market Size
Biologic Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biologic Therapeutics Drugs market is segmented into
Humans
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics

Segment by Application, the Biologic Therapeutics Drugs market is segmented into
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others

Regional and Country-level Analysis
The Biologic Therapeutics Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biologic Therapeutics Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biologic Therapeutics Drugs Market Share Analysis
Biologic Therapeutics Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biologic Therapeutics Drugs business, the date to enter into the Biologic Therapeutics Drugs market, Biologic Therapeutics Drugs product introduction, recent developments, etc.

The major vendors covered:
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies

レポート目次

1 Study Coverage
1.1 Biologic Therapeutics Drugs Product Introduction
1.2 Market Segments
1.3 Key Biologic Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Type
1.4.2 Humans
1.4.3 Avian Cell Culture
1.4.4 Yeast
1.4.5 Bacteria
1.4.6 Insects Cell Culture
1.4.7 Transgenics
1.5 Market by Application
1.5.1 Global Biologic Therapeutics Drugs Market Size Growth Rate by Application
1.5.2 Rheumatoid Arthritis
1.5.3 Anemia
1.5.4 Cancer
1.5.5 Diabetes
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biologic Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Biologic Therapeutics Drugs Revenue 2015-2026
2.1.2 Global Biologic Therapeutics Drugs Sales 2015-2026
2.2 Global Biologic Therapeutics Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biologic Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biologic Therapeutics Drugs Competitor Landscape by Players
3.1 Biologic Therapeutics Drugs Sales by Manufacturers
3.1.1 Biologic Therapeutics Drugs Sales by Manufacturers (2015-2020)
3.1.2 Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Biologic Therapeutics Drugs Revenue by Manufacturers
3.2.1 Biologic Therapeutics Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Biologic Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologic Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologic Therapeutics Drugs Revenue in 2019
3.2.5 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biologic Therapeutics Drugs Price by Manufacturers
3.4 Biologic Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Biologic Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologic Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Biologic Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biologic Therapeutics Drugs Market Size by Type (2015-2020)
4.1.1 Global Biologic Therapeutics Drugs Sales by Type (2015-2020)
4.1.2 Global Biologic Therapeutics Drugs Revenue by Type (2015-2020)
4.1.3 Biologic Therapeutics Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologic Therapeutics Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologic Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Biologic Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Biologic Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologic Therapeutics Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Biologic Therapeutics Drugs Market Size by Application (2015-2020)
5.1.1 Global Biologic Therapeutics Drugs Sales by Application (2015-2020)
5.1.2 Global Biologic Therapeutics Drugs Revenue by Application (2015-2020)
5.1.3 Biologic Therapeutics Drugs Price by Application (2015-2020)
5.2 Biologic Therapeutics Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologic Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Biologic Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologic Therapeutics Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Biologic Therapeutics Drugs by Country
6.1.1 North America Biologic Therapeutics Drugs Sales by Country
6.1.2 North America Biologic Therapeutics Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biologic Therapeutics Drugs Market Facts & Figures by Type
6.3 North America Biologic Therapeutics Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Biologic Therapeutics Drugs by Country
7.1.1 Europe Biologic Therapeutics Drugs Sales by Country
7.1.2 Europe Biologic Therapeutics Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologic Therapeutics Drugs Market Facts & Figures by Type
7.3 Europe Biologic Therapeutics Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Biologic Therapeutics Drugs by Region
8.1.1 Asia Pacific Biologic Therapeutics Drugs Sales by Region
8.1.2 Asia Pacific Biologic Therapeutics Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Type
8.3 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Biologic Therapeutics Drugs by Country
9.1.1 Latin America Biologic Therapeutics Drugs Sales by Country
9.1.2 Latin America Biologic Therapeutics Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biologic Therapeutics Drugs Market Facts & Figures by Type
9.3 Central & South America Biologic Therapeutics Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Biologic Therapeutics Drugs by Country
10.1.1 Middle East and Africa Biologic Therapeutics Drugs Sales by Country
10.1.2 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biologic Therapeutics Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Biologic Therapeutics Drugs Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Description and Business Overview
11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis Biologic Therapeutics Drugs Products Offered
11.3.5 Novartis Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Biologic Therapeutics Drugs Products Offered
11.4.5 Merck Related Developments
11.5 Smith Medical
11.5.1 Smith Medical Corporation Information
11.5.2 Smith Medical Description and Business Overview
11.5.3 Smith Medical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Smith Medical Biologic Therapeutics Drugs Products Offered
11.5.5 Smith Medical Related Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Description and Business Overview
11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Products Offered
11.6.5 GlaxoSmithKline Related Developments
11.7 Concord Biotech
11.7.1 Concord Biotech Corporation Information
11.7.2 Concord Biotech Description and Business Overview
11.7.3 Concord Biotech Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Concord Biotech Biologic Therapeutics Drugs Products Offered
11.7.5 Concord Biotech Related Developments
11.8 Aurobindo Pharma
11.8.1 Aurobindo Pharma Corporation Information
11.8.2 Aurobindo Pharma Description and Business Overview
11.8.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Products Offered
11.8.5 Aurobindo Pharma Related Developments
11.9 H. Lundbeck
11.9.1 H. Lundbeck Corporation Information
11.9.2 H. Lundbeck Description and Business Overview
11.9.3 H. Lundbeck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 H. Lundbeck Biologic Therapeutics Drugs Products Offered
11.9.5 H. Lundbeck Related Developments
11.10 Retractable Technologies
11.10.1 Retractable Technologies Corporation Information
11.10.2 Retractable Technologies Description and Business Overview
11.10.3 Retractable Technologies Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Retractable Technologies Biologic Therapeutics Drugs Products Offered
11.10.5 Retractable Technologies Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biologic Therapeutics Drugs Products Offered
11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biologic Therapeutics Drugs Market Estimates and Projections by Region
12.1.1 Global Biologic Therapeutics Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Biologic Therapeutics Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Biologic Therapeutics Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Biologic Therapeutics Drugs Sales Forecast (2021-2026)
12.2.2 North America: Biologic Therapeutics Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Biologic Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Biologic Therapeutics Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Biologic Therapeutics Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Biologic Therapeutics Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Biologic Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biologic Therapeutics Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biologic Therapeutics Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biologic Therapeutics Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biologic Therapeutics Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Biologic Therapeutics Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Biologic Therapeutics Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Biologic Therapeutics Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Biologic Therapeutics Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biologic Therapeutics Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biologic Therapeutics Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biologic Therapeutics Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biologic Therapeutics Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biologic Therapeutics Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologic Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Biologic Therapeutics Drugs Market Segments
Table 2. Ranking of Global Top Biologic Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologic Therapeutics Drugs Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Humans
Table 5. Major Manufacturers of Avian Cell Culture
Table 6. Major Manufacturers of Yeast
Table 7. Major Manufacturers of Bacteria
Table 8. Major Manufacturers of Insects Cell Culture
Table 9. Major Manufacturers of Transgenics
Table 10. Global Biologic Therapeutics Drugs Market Size Growth Rate by Application 2020-2026 (MT)
Table 11. Global Biologic Therapeutics Drugs Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 12. Global Biologic Therapeutics Drugs Sales by Regions 2015-2020 (MT)
Table 13. Global Biologic Therapeutics Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Biologic Therapeutics Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Biologic Therapeutics Drugs Sales by Manufacturers (2015-2020) (MT)
Table 16. Global Biologic Therapeutics Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Biologic Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics Drugs as of 2019)
Table 19. Biologic Therapeutics Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Biologic Therapeutics Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Biologic Therapeutics Drugs Price (2015-2020) (USD/Kg)
Table 22. Biologic Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Biologic Therapeutics Drugs Product Type
Table 24. Date of International Manufacturers Enter into Biologic Therapeutics Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 27. Global Biologic Therapeutics Drugs Sales Share by Type (2015-2020)
Table 28. Global Biologic Therapeutics Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Biologic Therapeutics Drugs Revenue Share by Type (2015-2020)
Table 30. Biologic Therapeutics Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 31. Global Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 32. Global Biologic Therapeutics Drugs Sales Share by Application (2015-2020)
Table 33. North America Biologic Therapeutics Drugs Sales by Country (2015-2020) (MT)
Table 34. North America Biologic Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Biologic Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Biologic Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 38. North America Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 40. North America Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Biologic Therapeutics Drugs Sales by Country (2015-2020) (MT)
Table 42. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Biologic Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 46. Europe Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 48. Europe Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2015-2020) (MT)
Table 50. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 54. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 56. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Biologic Therapeutics Drugs Sales by Country (2015-2020) (MT)
Table 58. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Biologic Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 62. Latin America Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 64. Latin America Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2015-2020) (MT)
Table 66. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Biologic Therapeutics Drugs Sales by Type (2015-2020) (MT)
Table 70. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Biologic Therapeutics Drugs Sales by Application (2015-2020) (MT)
Table 72. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Major Businesses
Table 75. Pfizer Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 76. Pfizer Product
Table 77. Pfizer Recent Development
Table 78. AstraZeneca Corporation Information
Table 79. AstraZeneca Description and Major Businesses
Table 80. AstraZeneca Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 81. AstraZeneca Product
Table 82. AstraZeneca Recent Development
Table 83. Novartis Corporation Information
Table 84. Novartis Description and Major Businesses
Table 85. Novartis Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 86. Novartis Product
Table 87. Novartis Recent Development
Table 88. Merck Corporation Information
Table 89. Merck Description and Major Businesses
Table 90. Merck Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 91. Merck Product
Table 92. Merck Recent Development
Table 93. Smith Medical Corporation Information
Table 94. Smith Medical Description and Major Businesses
Table 95. Smith Medical Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 96. Smith Medical Product
Table 97. Smith Medical Recent Development
Table 98. GlaxoSmithKline Corporation Information
Table 99. GlaxoSmithKline Description and Major Businesses
Table 100. GlaxoSmithKline Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Recent Development
Table 103. Concord Biotech Corporation Information
Table 104. Concord Biotech Description and Major Businesses
Table 105. Concord Biotech Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 106. Concord Biotech Product
Table 107. Concord Biotech Recent Development
Table 108. Aurobindo Pharma Corporation Information
Table 109. Aurobindo Pharma Description and Major Businesses
Table 110. Aurobindo Pharma Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 111. Aurobindo Pharma Product
Table 112. Aurobindo Pharma Recent Development
Table 113. H. Lundbeck Corporation Information
Table 114. H. Lundbeck Description and Major Businesses
Table 115. H. Lundbeck Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. H. Lundbeck Product
Table 117. H. Lundbeck Recent Development
Table 118. Retractable Technologies Corporation Information
Table 119. Retractable Technologies Description and Major Businesses
Table 120. Retractable Technologies Biologic Therapeutics Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 121. Retractable Technologies Product
Table 122. Retractable Technologies Recent Development
Table 123. Global Biologic Therapeutics Drugs Sales Forecast by Regions (2021-2026) (MT)
Table 124. Global Biologic Therapeutics Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Biologic Therapeutics Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Biologic Therapeutics Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Biologic Therapeutics Drugs Sales Forecast by Country (2021-2026) (MT)
Table 128. North America: Biologic Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Biologic Therapeutics Drugs Sales Forecast by Country (2021-2026) (MT)
Table 130. Europe: Biologic Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Biologic Therapeutics Drugs Sales Forecast by Region (2021-2026) (MT)
Table 132. Asia Pacific: Biologic Therapeutics Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Biologic Therapeutics Drugs Sales Forecast by Country (2021-2026) (MT)
Table 134. Latin America: Biologic Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Biologic Therapeutics Drugs Sales Forecast by Country (2021-2026) (MT)
Table 136. Middle East and Africa: Biologic Therapeutics Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Biologic Therapeutics Drugs Players
Table 141. Biologic Therapeutics Drugs Customers List
Table 142. Biologic Therapeutics Drugs Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Therapeutics Drugs Product Picture
Figure 2. Global Biologic Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Humans Product Picture
Figure 4. Avian Cell Culture Product Picture
Figure 5. Yeast Product Picture
Figure 6. Bacteria Product Picture
Figure 7. Insects Cell Culture Product Picture
Figure 8. Transgenics Product Picture
Figure 9. Global Biologic Therapeutics Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Rheumatoid Arthritis
Figure 11. Anemia
Figure 12. Cancer
Figure 13. Diabetes
Figure 14. Others
Figure 15. Biologic Therapeutics Drugs Report Years Considered
Figure 16. Global Biologic Therapeutics Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Biologic Therapeutics Drugs Sales 2015-2026 (MT)
Figure 18. Global Biologic Therapeutics Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Biologic Therapeutics Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Biologic Therapeutics Drugs Sales Market Share by Region in 2019
Figure 21. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Biologic Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 23. Global Biologic Therapeutics Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Biologic Therapeutics Drugs Revenue in 2019
Figure 25. Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Biologic Therapeutics Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Biologic Therapeutics Drugs Sales Market Share by Type in 2019
Figure 28. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Biologic Therapeutics Drugs Revenue Market Share by Type in 2019
Figure 30. Global Biologic Therapeutics Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Biologic Therapeutics Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Biologic Therapeutics Drugs Sales Market Share by Application in 2019
Figure 33. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Biologic Therapeutics Drugs Revenue Market Share by Application in 2019
Figure 35. North America Biologic Therapeutics Drugs Sales Growth Rate 2015-2020 (MT)
Figure 36. North America Biologic Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Biologic Therapeutics Drugs Sales Market Share by Country in 2019
Figure 38. North America Biologic Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 40. U.S. Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 42. Canada Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Biologic Therapeutics Drugs Market Share by Type in 2019
Figure 44. North America Biologic Therapeutics Drugs Market Share by Application in 2019
Figure 45. Europe Biologic Therapeutics Drugs Sales Growth Rate 2015-2020 (MT)
Figure 46. Europe Biologic Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Biologic Therapeutics Drugs Sales Market Share by Country in 2019
Figure 48. Europe Biologic Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 50. Germany Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 52. France Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 54. U.K. Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 56. Italy Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 58. Russia Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Biologic Therapeutics Drugs Market Share by Type in 2019
Figure 60. Europe Biologic Therapeutics Drugs Market Share by Application in 2019
Figure 61. Asia Pacific Biologic Therapeutics Drugs Sales Growth Rate 2015-2020 (MT)
Figure 62. Asia Pacific Biologic Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region in 2019
Figure 65. China Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 66. China Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 68. Japan Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 70. South Korea Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 72. India Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 74. Australia Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 76. Taiwan Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 78. Indonesia Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 80. Thailand Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 82. Malaysia Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 84. Philippines Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 86. Vietnam Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Biologic Therapeutics Drugs Market Share by Type in 2019
Figure 88. Asia Pacific Biologic Therapeutics Drugs Market Share by Application in 2019
Figure 89. Latin America Biologic Therapeutics Drugs Sales Growth Rate 2015-2020 (MT)
Figure 90. Latin America Biologic Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Biologic Therapeutics Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 94. Mexico Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 96. Brazil Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 98. Argentina Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Biologic Therapeutics Drugs Market Share by Type in 2019
Figure 100. Latin America Biologic Therapeutics Drugs Market Share by Application in 2019
Figure 101. Middle East and Africa Biologic Therapeutics Drugs Sales Growth Rate 2015-2020 (MT)
Figure 102. Middle East and Africa Biologic Therapeutics Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 106. Turkey Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 108. Saudi Arabia Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Biologic Therapeutics Drugs Sales Growth Rate (2015-2020) (MT)
Figure 110. U.A.E Biologic Therapeutics Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Biologic Therapeutics Drugs Market Share by Type in 2019
Figure 112. Middle East and Africa Biologic Therapeutics Drugs Market Share by Application in 2019
Figure 113. North America Biologic Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. North America Biologic Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Biologic Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Europe Biologic Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Biologic Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Asia Pacific Biologic Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Biologic Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. Latin America Biologic Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Biologic Therapeutics Drugs Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Middle East and Africa Biologic Therapeutics Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed